Chemical Synthetic Biology

化学合成生物学

• 批准号: 1000231971-2017
• 负责人: Budisa, Nediljko
• 金额: $ 14.57万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=695370
• 关键词: Chemical; Synthetic; Biology

Modern genetic engineers aim at building living systems in order to establish technologies to produce virtually every imaginable medically or industrially interesting substance. The long-term objective behind the proposed CRC Tier 1 Research in Chemical Synthetic Biology is to create highly modular bio-inspired materials useful for both academia and (bio)industrial purposes. Prof Budisa will achieve these objectives by (i) developing protein-based natural polymer materials with the potential to revolutionize bone surgery and wound healing; (ii) engineering biological alternatives to conductive carbon nanotubes for use in energy storage, water filters, bio-electronic devices and more.

现代基因工程师的目标是建立生命系统，以便建立生产几乎所有可以想象的医学或工业上感兴趣的物质的技术。拟议的CRC Tier 1化学合成生物学研究背后的长期目标是创建可用于学术界和（生物）工业目的的高度模块化的生物启发材料。Budisa教授将通过以下方式实现这些目标：（i）开发基于蛋白质的天然聚合物材料，具有彻底改变骨外科手术和伤口愈合的潜力;（ii）设计导电碳纳米管的生物替代品，用于储能，水过滤器，生物电子设备等。